Back to today’s briefing

Story perspectives

Galatea Bio Secures $25M to Revolutionize Genomic Research

3/28/2025

26 5

Summary

Story summary

Galatea Bio, a Miami biotech innovator, has secured $25 million to supercharge its biobank and advance precision medicine using AI-powered genomic research. Established in 2021, the company aims to sequence 10 million individuals, prioritizing diverse populations. This funding will propel genetic risk analysis, drug discovery, and vital partnerships, bridging critical gaps in genomic research.

1 of 1

Story summary

Galatea Bio, a Miami biotech innovator, has secured $25 million to supercharge its biobank and advance precision medicine using AI-powered genomic research. Established in 2021, the company aims to sequence 10 million individuals, prioritizing diverse populations. This funding will propel genetic risk analysis, drug discovery, and vital partnerships, bridging critical gaps in genomic research.